Imovax Polio, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv poliomijelitisa, inaktivirano
Name | Imovax Polio, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv poliomijelitisa, inaktivirano |
---|---|
Marketing Authorisation Number | HR-H-527075219 |
Active Substance | poliovirus tip 1, soj Mahoney (inaktiviran) poliovirus tip 2, soj MEF-1 (inaktiviran) poliovirus tip 3, soj Saukett (inaktiviran) |
Composition | 1 doza (0,5 ml) sadržava: Poliovirus tip 1 Mahoney soj (inaktiviran): 29 D antigen jedinica, Poliovirus tip 2 MEF-1 soj (inaktiviran): 7 D antigen jedinica, Poliovirus tip 3 Saukett soj (inaktiviran): 26 D antigen jedinica |
Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
Manufacturer | Sanofi-Aventis Zrt., Budimpešta, Mađarska Sanofi Winthrop Industrie, Val de Reuil, Francuska Sanofi Winthrop Industrie, Marcy L Etoile , Francuska |
Marketing Authorisation Holder | Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
Marketing Authorisation Date | 24.12.2024 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/18-02/147 |
Registration Number | 381-12-01/171-24-46 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ograničeni recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | J07BF03 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |